Abstract
Mastocytosis has a highly variable clinical expression, and systemic mastocytosis is occasionally associated with a myeloproliferative or a myelodysplastic disorder. These patients often present without skin involvement and have a very poor prognosis. We report a 72-year-old man with this condition who had spells of flushing and dyspnea, myelofibrosis, and high serum and urine histamine levels.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Drug Therapy, Combination
-
Histamine H1 Antagonists / therapeutic use
-
Histamine H2 Antagonists / therapeutic use
-
Humans
-
Hydroxyzine / therapeutic use
-
Male
-
Mastocytosis / diagnosis*
-
Mastocytosis / drug therapy
-
Mastocytosis / physiopathology
-
Ranitidine / therapeutic use
Substances
-
Histamine H1 Antagonists
-
Histamine H2 Antagonists
-
Hydroxyzine
-
Ranitidine